article thumbnail

Classiq Launches Quantum Center for Life Sciences with NVIDIA

HIT Consultant

What You Should Know: – Classiq , NVIDIA , and Tel Aviv Sourasky Medical Center have established a new initiative, the Quantum Computing for Life Sciences & Healthcare Center, to develop and implement quantum algorithms and applications in these domains.

article thumbnail

JPMorgan Establishes Life Sciences Private Equity Division

HIT Consultant

Morgan Asset Management announced the establishment of a new life sciences private equity team, Life Sciences Private Capital. – The Life Sciences Private Capital team will sit within J.P. . – The Life Sciences Private Capital team will sit within J.P. Anya Schiess.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Dot Compliance Launches First AI Based ChatGPT Powered eQMS for Life Sciences

HIT Consultant

What You Should Know: Dot Compliance , a leading provider of eQMS compliance solutions for the life sciences sector, has introduced an industry-first, ready-to-use AI-Based electronic Quality Management System for life sciences, powered by an embedded generative and predictive artificial intelligence.

article thumbnail

Accenture, Salesforce Partner on Generative AI for Life Sciences Companies

HIT Consultant

What You Should Know: – Accenture and Salesforce are investing in the development of Salesforce Life Sciences Cloud, focusing on innovation, assets, and accelerators powered by data and artificial intelligence (AI) to help life sciences companies create sustainable value and drive growth.

article thumbnail

Exploring The Value of Metaverse Use Cases in Life Sciences

HIT Consultant

While the pharmaceutical industry and life sciences are often criticized for slow technological adoption, the metaverse presents an enormous opportunity for early adoption built on a clear understanding of value. He has 25 years of tech experience, including 16 years in the life sciences industry.

article thumbnail

Healthcare & Life Science M&A Activity Plummets 1H’22

HIT Consultant

What You Should Know: – The index of Healthcare & Life Science equities tracked by Stout was down 16.8% – Healthcare & Life Science M&A activity plummeted to 338 deals in Q2 2022 versus 535 in Q2 2021 and a record 565 deals in Q4 2021. Medical Device equities were down 18.5%

article thumbnail

2023 Life Sciences Digital Pathology Adoption Survey Report

HIT Consultant

What You Should Know: Nearly three-fourths of life sciences organizations surveyed have invested in digital pathology to advance drug research and development (R&D), according to new research commissioned by Proscia®. Pharmaceutical leaders should consider fully incorporating this data into their workflows.